9月26日，迈得医疗盘中上涨2.24%，截至10:24，报20.08元/股，成交2617.97万元，换手率0.80%，总市 值33.38亿元。 资金流向方面，主力资金净流入60.86万元，特大单买入0.00元，占比0.00%，卖出198.31万元，占比 7.58%；大单买入768.59万元，占比29.36%，卖出509.42万元，占比19.46%。 迈得医疗今年以来股价涨85.93%，近5个交易日涨8.48%，近20日涨2.08%，近60日涨30.05%。 截至6月30日，迈得医疗股东户数3805.00，较上期减少4.80%；人均流通股43684股，较上期增加 5.05%。2025年1月-6月，迈得医疗实现营业收入1.41亿元，同比减少14.75%；归母净利润604.51万元， 同比减少38.81%。 分红方面，迈得医疗A股上市后累计派现2.02亿元。近三年，累计派现9929.75万元。 机构持仓方面，截止2025年6月30日，迈得医疗十大流通股东中，华夏行业景气混合A（003567）位居 第四大流通股东，持股366.97万股，持股数量较上期不变。华夏远见成长一年持有混合A（016250）位 居第七大流通股东 ...

9月26日，英科医疗盘中上涨2.01%，截至10:22，报37.54元/股，成交1.71亿元，换手率1.00%，总市值 245.81亿元。 资金流向方面，主力资金净流出745.45万元，特大单买入412.42万元，占比2.41%，卖出658.84万元，占 比3.86%；大单买入2395.34万元，占比14.02%，卖出2894.37万元，占比16.94%。 英科医疗今年以来股价涨49.08%，近5个交易日涨5.27%，近20日涨2.21%，近60日涨46.64%。 资料显示，英科医疗科技股份有限公司位于山东省淄博市临淄区齐鲁化学工业园清田路18号,香港湾仔 皇后大道东248号阳光中心40楼，成立日期2009年7月20日，上市日期2017年7月21日，公司主营业务涉 及涵盖个人防护、康复护理、其他产品三大板块。主营业务收入构成为：个人防护类91.47%，康复护 理类4.75%，其他产品3.77%。 英科医疗所属申万行业为：医药生物-医疗器械-医疗耗材。所属概念板块包括：医用耗材、智慧医疗、 抗原检测、医疗器械、跨境电商等。 截至6月30日，英科医疗股东户数6.00万，较上期减少2.96%；人均流通股7825股， ...

英科医疗今年以来股价涨46.94%，近5个交易日涨3.99%，近20日跌1.73%，近60日涨45.15%。 资料显示，英科医疗科技股份有限公司位于山东省淄博市临淄区齐鲁化学工业园清田路18号,香港湾仔 皇后大道东248号阳光中心40楼，成立日期2009年7月20日，上市日期2017年7月21日，公司主营业务涉 及涵盖个人防护、康复护理、其他产品三大板块。主营业务收入构成为：个人防护类91.47%，康复护 理类4.75%，其他产品3.77%。 9月25日，英科医疗盘中下跌2.01%，截至13:50，报37.00元/股，成交4.68亿元，换手率2.67%，总市值 242.27亿元。 资金流向方面，主力资金净流出1567.62万元，特大单买入1279.07万元，占比2.73%，卖出2541.32万 元，占比5.43%；大单买入8113.51万元，占比17.34%，卖出8418.87万元，占比17.99%。 截至6月30日，英科医疗股东户数6.00万，较上期减少2.96%；人均流通股7825股，较上期增加3.07%。 2025年1月-6月，英科医疗实现营业收入49.13亿元，同比增长8.90%；归母净利润7.10亿 ...

嘉事堂今年以来股价涨8.94%，近5个交易日涨0.22%，近20日跌1.42%，近60日涨3.43%。 分红方面，嘉事堂A股上市后累计派现8.74亿元。近三年，累计派现2.16亿元。 今年以来嘉事堂已经1次登上龙虎榜，最近一次登上龙虎榜为5月8日，当日龙虎榜净买入-5345.21万 元；买入总计3524.90万元 ，占总成交额比6.51%；卖出总计8870.11万元 ，占总成交额比16.37%。 9月25日，嘉事堂盘中上涨2.06%，截至13:32，报13.89元/股，成交4951.80万元，换手率1.24%，总市值 40.52亿元。 截至9月10日，嘉事堂股东户数2.20万，较上期减少8.40%；人均流通股13248股，较上期增加9.17%。 2025年1月-6月，嘉事堂实现营业收入96.99亿元，同比减少24.45%；归母净利润1.07亿元，同比减少 36.24%。 资金流向方面，主力资金净流入450.95万元，特大单买入480.36万元，占比9.70%，卖出108.23万元，占 比2.19%；大单买入883.12万元，占比17.83%，卖出804.30万元，占比16.24%。 资料显示，嘉事堂药业股份有 ...

Company Overview - Dongfulong Technology Group Co., Ltd. is located in Minhang District, Shanghai, established on December 25, 1993, and listed on February 1, 2011. The company specializes in the research, design, production, sales, and service of medical freeze-dryers and freeze-drying systems [1]. Financial Performance - As of June 30, 2025, Dongfulong achieved operating revenue of 2.429 billion yuan, representing a year-on-year growth of 6.01%. However, the net profit attributable to shareholders decreased by 59.71% to 45.9195 million yuan [2]. - The company has cumulatively distributed dividends of 1.782 billion yuan since its A-share listing, with 512 million yuan distributed over the past three years [3]. Stock Performance - On September 25, Dongfulong's stock price increased by 2.19%, reaching 14.46 yuan per share, with a total market capitalization of 11.074 billion yuan. The stock has seen a year-to-date increase of 9.75% [1]. - The stock's trading volume on September 25 was 70.291 million yuan, with a turnover rate of 0.88%. The net outflow of main funds was 1.516 million yuan, while large orders saw a buy of 9.4811 million yuan and a sell of 12.2223 million yuan [1]. Shareholder Structure - As of June 30, 2025, the number of shareholders increased to 32,100, with an average of 17,526 circulating shares per person, a decrease of 2.30% from the previous period [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited held 7.3336 million shares, a decrease of 2.1354 million shares from the previous period, while Southern CSI 1000 ETF entered as a new shareholder with 3.5502 million shares [3]. Business Segments - Dongfulong's main business revenue composition includes: 44.92% from the formulation division, 29.83% from the bioprocess division, 9.19% from the engineering division, 9.16% from the food division, 6.81% from after-sales service and parts, and 0.09% from other sources [1].

9月25日，迈瑞医疗盘中上涨2.01%，截至11:20，报238.60元/股，成交12.90亿元，换手率0.45%，总市 值2892.89亿元。 截至6月30日，迈瑞医疗股东户数9.16万，较上期减少0.68%；人均流通股13241股，较上期增加0.69%。 2025年1月-6月，迈瑞医疗实现营业收入167.43亿元，同比减少18.45%；归母净利润50.69亿元，同比减 少32.96%。 分红方面，迈瑞医疗A股上市后累计派现336.99亿元。近三年，累计派现233.88亿元。 机构持仓方面，截止2025年6月30日，迈瑞医疗十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股1.31亿股，相比上期减少302.52万股。易方达创业板ETF（159915）位居第五大流通股 东，持股1365.26万股，相比上期减少3.01万股。华宝中证医疗ETF（512170）位居第六大流通股东，持 股1101.24万股，相比上期增加88.93万股。华泰柏瑞沪深300ETF（510300）位居第七大流通股东，持股 1081.65万股，相比上期增加88.31万股。易方达沪深300医药ETF（512010）位居第八大流通股 ...

Company Overview - Tsinghua Tongfang Co., Ltd. is located in Beijing and was established on January 11, 1999, with its listing date on October 30, 2009. The company operates in two main business segments: outdoor products and semiconductor chips, which belong to the outdoor goods industry and semiconductor industry respectively [1]. Financial Performance - As of June 30, Tsinghua Tongfang reported a revenue of 653 million yuan for the first half of 2025, representing a year-on-year decrease of 7.82%. The net profit attributable to shareholders was 20.09 million yuan, down 76.50% year-on-year [2]. - The company has cumulatively distributed 509 million yuan in dividends since its A-share listing, with a total of 30.42 million yuan distributed over the past three years [3]. Stock Performance - On September 25, Tsinghua Tongfang's stock price decreased by 2.19%, trading at 8.94 yuan per share, with a total market capitalization of 7.9 billion yuan. The stock has increased by 27.73% year-to-date, but has seen a decline of 3.46% over the last five trading days and 4.99% over the last 20 days [1]. - The company has experienced a net outflow of 38.14 million yuan in principal funds, with significant selling pressure observed [1]. Shareholder Information - As of June 30, the number of shareholders increased by 31.04% to 58,000, while the average number of circulating shares per person decreased by 23.69% to 15,220 shares [2].

Core Viewpoint - Sanyou Medical's stock price has shown fluctuations, with a year-to-date increase of 12.89% and a recent decline of 13.12% over the past 20 days, indicating volatility in the market [1][2]. Company Overview - Sanyou Medical, established on April 19, 2005, and listed on April 9, 2020, specializes in the research, production, and sales of medical orthopedic implants and ultrasonic power equipment and consumables [1]. - The company's revenue composition includes spinal implant consumables (63.80%), active devices and supporting accessories (31.51%), trauma implant consumables (3.53%), and others (1.16%) [1]. Financial Performance - For the first half of 2025, Sanyou Medical reported a revenue of 250 million yuan, representing a year-on-year growth of 17.77% [2]. - The net profit attributable to the parent company reached 36.60 million yuan, showing a significant year-on-year increase of 2083.64% [2]. Shareholder Information - As of June 30, 2025, the number of shareholders increased by 12.61% to 7,108, while the average circulating shares per person decreased by 11.20% to 34,954 shares [2]. - Cumulative cash dividends since the A-share listing amount to 113 million yuan, with 39.75 million yuan distributed over the past three years [3]. Institutional Holdings - As of June 30, 2025, the top ten circulating shareholders include notable funds, with Rongtong Health Industry Flexible Allocation Mixed A/B holding 9.98 million shares, a decrease of 1.52 million shares from the previous period [3].

资料显示，北京瑞迈特医疗科技股份有限公司位于北京市丰台区丽泽路16号院4号楼北京汇亚大厦17层 10号，成立日期2001年7月27日，上市日期2022年11月1日，公司主营业务涉及研发、生产、销售呼吸健 康领域医疗设备与耗材产品及相关服务,为以阻塞型睡眠呼吸暂停低通气综合征(OSA)为主的睡眠呼吸暂 停低通气综合征(SAHS)患者以及以慢性阻塞性肺疾病(COPD)为主的呼吸功能不全(Respiratory Insufficiency)患者提供全周期(从诊断、治疗到慢病管理)、多场景(从医疗机构到家庭)的治疗服务整体解 决方案。主营业务收入构成为：家用呼吸诊疗产品64.19%，耗材32.67%，医用产品3.05%，其他 0.10%。 瑞迈特所属申万行业为：医药生物-医疗器械-医疗设备。所属概念板块包括：小盘、医疗器械、融资融 券、机器人概念等。 9月24日，瑞迈特盘中上涨2.04%，截至13:40，报85.13元/股，成交4251.75万元，换手率0.89%，总市值 76.28亿元。 资金流向方面，主力资金净流出135.50万元，大单买入461.11万元，占比10.85%，卖出596.61万元，占 比14.03 ...

9月24日，陇神戎发盘中上涨2.10%，截至13:38，报9.71元/股，成交4516.86万元，换手率1.55%，总市 值29.45亿元。 资金流向方面，主力资金净流入156.88万元，特大单买入100.63万元，占比2.23%，卖出0.00元，占比 0.00%；大单买入842.75万元，占比18.66%，卖出786.50万元，占比17.41%。 陇神戎发所属申万行业为：医药生物-中药Ⅱ-中药Ⅲ。所属概念板块包括：甘肃国资、医药电商、中 药、小盘、医疗器械等。 截至9月10日，陇神戎发股东户数2.78万，较上期减少0.71%；人均流通股10853股，较上期增加0.71%。 2025年1月-6月，陇神戎发实现营业收入4.96亿元，同比减少9.91%；归母净利润2795.61万元，同比增长 30.31%。 分红方面，陇神戎发A股上市后累计派现4264.16万元。近三年，累计派现2426.76万元。 机构持仓方面，截止2025年6月30日，陇神戎发十大流通股东中，汇添富中证中药ETF（560080）位居 第六大流通股东，持股97.85万股，相比上期减少10.16万股。 责任编辑：小浪快报 陇神戎发今年以来股价涨1 ...